Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0569-2025

Baxter MiniCap Extended Life PD Transfer Set (short) with Titanium Spike, Part Number T5C4326K; use in Peritoneal Dialysis Recall

Baxter MiniCap Extended Life PD Transfer Set (short) with Titanium Spike, Part Number T5C4326K; use in Peritoneal Dialysis

FDA recall Class II

Ongoing

FDA lists this Class II recall for Baxter MiniCap Extended Life PD Transfer Set (short) with Titanium Spike, Part Number T5C4326K; use in Peritoneal Dialysis. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0569-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 23, 2024
FDA report date
Dec 4, 2024
Quantity in commerce
13376 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Baxter MiniCap Extended Life PD Transfer Set (short) with Titanium Spike, Part Number T5C4326K; use in Peritoneal Dialysis

Affected model & UDI checker

Search the exact identifiers published for Z-0569-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedBaxter MiniCap Extended Life PD Transfer Set (short) with Titanium Spike, Part Number T5C4326K; use in Peritoneal DialysisCheck source notice0085412150703
FDA code information

UDI/DI 0085412150703, Lot/Serial Numbers: H23J02025, H23L04043, H23L05057, H23L05073, H24A29041, H24C01061, H24E13061, H24G15062

View the original FDA recall notice

Why was this product recalled?

There has been an increase in the number of complaints related to the separation of the female connector from the main body of the transfer set.

What actions did Baxter Healthcare Corporation take?

Baxter issued a SAFETY ALERT notice to its consignees on 10/23/2024 via USPS first class mail. The notice explains the issue and potential hazard involved. The notice addressed to dialysis providers indicated that if a patient contacts your clinic experiencing separation of the transfer set, to replace their transfer set and contact Baxter. Notices addressed to peritoneal patients provided the following instructions: "If you experience a separation of the transfer set, please close the transfer set twist clamp and do not cut the patient line. Contact your doctor and/or nurse immediately to arrange for a transfer set replacement and further guidance." Distributors were directed to notify their customers. For general questions regarding this communication, please contact Baxter Renal Home Care Services which can be reached at 800-284-4060, option 1, between the hours of 7:00 am and 6:00 pm Central Time, Monday through Friday.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology